Can we slow the rising incidence of childhood-onset autoimmune diabetes? The overload hypothesis - PubMed (original) (raw)
Review
Can we slow the rising incidence of childhood-onset autoimmune diabetes? The overload hypothesis
G Dahlquist. Diabetologia. 2006 Jan.
Abstract
Overload of the beta cell, mediated by a variety of mechanisms, may sensitise it to immune damage and apoptosis, and thus accelerate ongoing autoimmune processes leading to its destruction. Environmental risk determinants that may exert such overload effects include insulin resistance due to excess fat cell accumulation, and increased insulin requirement due to a high growth rate, physical stress (infection, inflammation) or psychological stress. The increasing incidence of childhood diabetes, and the shift to younger age at onset, is unlikely to be driven by environmental risk factors that have been associated with initiation of autoimmunity, e.g. virus infections or early infant feeding. Risk factors that may accelerate beta cell destruction have shown a steady increase in the population, and are more plausible causes of such a pattern of change. Child growth, weight and birthweight are well-established estimates of community wealth and increase in most countries of Europe. Overfeeding of children early in life leads to both accelerated growth and weight, and even a moderate excess of child growth, not necessarily associated with obesity, is associated with risk of type 1 diabetes. New, safe and effective immune-modulating drugs for possible arrest of the autoimmune process may become available in time, but in the interim these accelerating factors may be targeted. Public health programmes for pregnant mothers and young families, aiming at changing overfeeding and the sedentary lifestyle of the children would be preferable to other alternatives. Interventions such as these would be safe and could potentially influence future risks of type 1 and type 2 diabetes and other major threats to adult health.
Similar articles
- Childhood diabetes mellitus: recent advances & future prospects.
Dejkhamron P, Menon RK, Sperling MA. Dejkhamron P, et al. Indian J Med Res. 2007 Mar;125(3):231-50. Indian J Med Res. 2007. PMID: 17496353 Review. - Why diabetes incidence increases--a unifying theory.
Ludvigsson J. Ludvigsson J. Ann N Y Acad Sci. 2006 Oct;1079:374-82. doi: 10.1196/annals.1375.058. Ann N Y Acad Sci. 2006. PMID: 17130582 Review. - The genetic contribution to disease pathogenesis in childhood diabetes is greatest in the very young.
Shield JP, Wadsworth EJ, Baum JD. Shield JP, et al. Diabet Med. 1995 May;12(5):377-9. doi: 10.1111/j.1464-5491.1995.tb00498.x. Diabet Med. 1995. PMID: 7648797 - Diabetes in the young: a paediatric and epidemiological perspective.
Soltész G. Soltész G. Diabetologia. 2003 Apr;46(4):447-54. doi: 10.1007/s00125-003-1101-0. Epub 2003 Apr 11. Diabetologia. 2003. PMID: 12690439 Review. - Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the 'accelerator hypothesis' (2).
Betts P, Mulligan J, Ward P, Smith B, Wilkin T. Betts P, et al. Diabet Med. 2005 Feb;22(2):144-51. doi: 10.1111/j.1464-5491.2004.01368.x. Diabet Med. 2005. PMID: 15660730
Cited by
- Implication of Pappalysins and Stanniocalcins in the Bioavailability of IGF-I in Children With Type 1 Diabetes Mellitus.
Güemes M, Martín-Rivada Á, Corredor B, Enes P, Canelles S, Barrios V, Argente J. Güemes M, et al. J Endocr Soc. 2024 Apr 23;8(6):bvae081. doi: 10.1210/jendso/bvae081. eCollection 2024 Apr 6. J Endocr Soc. 2024. PMID: 38712328 Free PMC article. - Double diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition.
Bielka W, Przezak A, Molęda P, Pius-Sadowska E, Machaliński B. Bielka W, et al. Cardiovasc Diabetol. 2024 Feb 10;23(1):62. doi: 10.1186/s12933-024-02145-x. Cardiovasc Diabetol. 2024. PMID: 38341550 Free PMC article. Review. - An Oxylipin-Related Nutrient Pattern and Risk of Type 1 Diabetes in the Diabetes Autoimmunity Study in the Young (DAISY).
Buckner T, Johnson RK, Vanderlinden LA, Carry PM, Romero A, Onengut-Gumuscu S, Chen WM, Fiehn O, Frohnert BI, Crume T, Perng W, Kechris K, Rewers M, Norris JM. Buckner T, et al. Nutrients. 2023 Feb 14;15(4):945. doi: 10.3390/nu15040945. Nutrients. 2023. PMID: 36839302 Free PMC article. - Dietary fatty acid intake in childhood and the risk of islet autoimmunity and type 1 diabetes: the DIPP birth cohort study.
Hakola L, Vuorinen AL, Takkinen HM, Niinistö S, Ahonen S, Rautanen J, Peltonen EJ, Nevalainen J, Ilonen J, Toppari J, Veijola R, Knip M, Virtanen SM. Hakola L, et al. Eur J Nutr. 2023 Mar;62(2):847-856. doi: 10.1007/s00394-022-03035-2. Epub 2022 Oct 25. Eur J Nutr. 2023. PMID: 36284022 Free PMC article. - The association of physical activity to oral glucose tolerance test outcomes in multiple autoantibody positive children: The TEDDY Study.
Johnson SB, Tamura R, McIver KL, Pate RR, Driscoll KA, Melin J, Larsson HE, Haller MJ, Yang J; TEDDY Study Group. Johnson SB, et al. Pediatr Diabetes. 2022 Nov;23(7):1017-1026. doi: 10.1111/pedi.13382. Epub 2022 Jun 24. Pediatr Diabetes. 2022. PMID: 35702057 Free PMC article.
References
- Acta Paediatr. 2000 Oct;89(10):1231-7 - PubMed
- Diabetes. 2005 Jul;54(7):1899-906 - PubMed
- Arch Dis Child. 1974 Aug;49(8):616-20 - PubMed
- Diabetologia. 1991 Aug;34(8):579-83 - PubMed
- Diabetologia. 2002 Jun;45(6):783-91 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical